Cargando…

A Specific Spectrum of p53 Mutations in Lung Cancer from Smokers: Review of Mutations Compiled in the IARC p53 Database

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	1998
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533159/

Ejemplares similares

A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.
por: Hernandez-Boussard, T M, et al.
Publicado: (1998)

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
por: Halvorsen, Ann R., et al.
Publicado: (2016)

Mutations in p53, p53 protein overexpression and breast cancer survival
por: Rossner, Pavel, et al.
Publicado: (2009)

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2023)

Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity
por: Turrell, Frances K., et al.
Publicado: (2017)

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers
por: Liu, Yang, et al.
Publicado: (2007)

P53 mutations in gastric carcinomas.
por: Seruca, R., et al.
Publicado: (1992)

p53 mutation and expression in lymphoma.
por: Adamson, D. J., et al.
Publicado: (1995)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Cas9 activates the p53 pathway and selects for p53-inactivating mutations
por: Enache, Oana M., et al.
Publicado: (2020)

Cigarette smoking and p53 mutations in lung cancer and bladder cancer.
por: Husgafvel-Pursiainen, K, et al.
Publicado: (1996)

Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis
por: Iwahashi, Naoyuki, et al.
Publicado: (2022)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

Correction: Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53
por: Page, Angustias, et al.
Publicado: (2017)

Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
por: Zienolddiny, S, et al.
Publicado: (2001)

P63 and P73 Activation in Cancers with p53 Mutation
por: Cai, Bi-He, et al.
Publicado: (2022)

Broad-spectrum rescue compounds for structural p53 mutations: perspective on ‘Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site’
por: Wu, Jia-Le, et al.
Publicado: (2021)

Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
por: Aziz, Moammir H., et al.
Publicado: (2011)

Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.
por: el-Mahdani, N., et al.
Publicado: (1997)

Do Mutations Turn p53 into an Oncogene?
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis
por: Rockwell, Nathan C., et al.
Publicado: (2021)

Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy
por: Vadakekolathu, Jayakumar, et al.
Publicado: (2022)

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction
por: Clegg, Hilary V., et al.
Publicado: (2012)

Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
por: Hwang, Hye Jung, et al.
Publicado: (2020)

P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
por: Lasky, T, et al.
Publicado: (1996)

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998)

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
por: Szybka, M, et al.
Publicado: (2008)

Author Correction: Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability
por: Galanos, Panagiotis, et al.
Publicado: (2022)

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
por: Köbel, Martin, et al.
Publicado: (2016)

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020)

p53 Mutations and DNA Ploidy in Colorectal Adenocarcinomas
por: Campomenosi, Paola, et al.
Publicado: (1998)

Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53
por: Loh, Stewart N.
Publicado: (2020)

Detection of p53 mutations in precancerous gastric tissue
por: Morgan, C, et al.
Publicado: (2003)

Increased expression and mutation of p53 in choroidal melanoma.
por: Tobal, K., et al.
Publicado: (1992)

Spontaneous inactivating p53 mutations and the “selfish cell”
por: Sorscher, Steven M., et al.
Publicado: (2011)

Correction: The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner
por: Arsic, Nikola, et al.
Publicado: (2017)

p53MutaGene: an online tool to estimate the effect of p53 mutational status on gene regulation in cancer
por: Amelio, I, et al.
Publicado: (2016)

Administration of 4-hexylresorcinol increases p53-mediated transcriptional activity in oral cancer cells with the p53 mutation
por: Kang, Yei-Jin, et al.
Publicado: (2022)

p53 mutations and overexpression in locally advanced breast cancers.
por: Faille, A., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_u4lld48rj51l0lt7viklv76oer